Chronic pain and inflammation underlie many conditions that holistic practitioners face every day – from joint degeneration and neuropathy to migraines, menstrual disorders and post-exercise recovery.
However, the mainstream pharmaceutical toolkit remains limited by adverse effects, risks of dependency, and inability to address the basic biology of neuroinflammation.
This webinar invites you to explore palmitoylethanolamide (PEA) – a well-studied, internally produced lipid mediator that the human body actually uses to regulate pain and repair damaged tissue.
Specifically, we will focus on Levagen®+, Saanroo’s clinically validated PEA formulation powered by our patented LipiSperse® dispersion technology, which significantly improves the absorption and bioavailability of PEA.
chemical
Ramasamy V Venkatesh It will establish the scientific basis for the clinical use of PEA, and review its multi-receptor mechanism – mainly through PPAR-α activation, along with indirect modulation of CB1 and CB2 receptors and interactions with GPR55 and TRPV1. You will learn how this “parallel endocannabinoid” signaling pathway makes PEA uniquely suited to treat peripheral and central pain while avoiding psychoactive effects.
Dr. Venkatesh will also provide a comprehensive review of the clinical research on Levagen®+ across multiple pain and inflammation applications. Highlights include randomized, double-blind, placebo-controlled trials showing the effectiveness of Levagen®+ in joint pain and stiffness, severe menstrual pain, migraines, and exercise-induced muscle damage.
You will gain a deep understanding of how Levagen®+ can be applied in the care of diverse patient subgroups – not as a one-size-fits-all supplement, but as a precise tool that targets the endocannabinoid pathways associated with pain.
Sponsored by:
Ramasamy V Venkatesh He is a chemist with over 40 years of experience in healthcare, specializing in pharmaceuticals and nutraceuticals. He is the founder and managing director of Gencor Group worldwide. He has extensive international business experience in the pharmaceutical and nutritional sectors, having done business in more than 70 countries. His experience covers R&D management, scientific reviews, product development, clinical trials, branding and strategic partnerships, with a proven track record of success in launching branded products globally in the food market. Venkatesh serves on numerous advisory boards in the food and pharmaceutical industries. In 2024, he received the Nutri Champion Award from NutraIngredients in 2024, for the significant impact his work has had on the nutritional supplement industry. He is known for raising the bar by using high-quality, clinically backed ingredients.
Venkatesh is highly respected by colleagues, clients and the industry at large for his exceptional work ethic and selfless dedication. His commitment extends beyond his professional accomplishments, as he also works to promote equal opportunities and empowerment of women in business and sports.
